author-photo

Inge Marie Svane

Copenhagen University Hospital
University of Copenhagen
Herlev Hospital

345

Papers

9486

Citations

Citation Trend

Filter By

Papers (345) Sort By

Journal Conference Others

Two dosing regimens of nivolumab (NIVO) plus ipilimumab (IPI) for advanced (adv) melanoma: Three-year results of CheckMate 511.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive transfer with tumor-infiltrating lymphocytes in melanoma.

2021 Journal of Clinical Investigation
Show All
- Source
- Cite
- Save
Citations (0)
Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma.

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Comparison of Efficacy in Patients with Metastatic Melanoma Treated with Ipilimumab and Nivolumab Who Did or Did Not Discontinue Treatment Due to Immune-Related Adverse Events: A Real-World Data Study

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (0)
CTIM-23. EVIDENCE OF T CELL ACTIVATION AND INTRATUMORAL NIVOLUMAB-PRESENCE IN GLIOBLASTOMA PATIENTS TREATED WITH NIVOLUMAB AND BEVACIZUMAB

2021 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
Lynch syndrome-associated epithelial ovarian cancer and its immunological profile

2021 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase III trial, pembrolizumab versus placebo after complete resection of high-risk stage III melanoma.

2021 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Immune check point inhibitors are associated with a spectrum of cardiac events in patients with cancer.

2021 European Heart Journal
Show All
- Source
- Cite
- Save
Citations (1)
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial.

2021 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (18)